Michael Dennis

Michael or Mike Dennis may refer to: * Michael Aaron Dennis, American author * Michael J. Dennis, African-American filmmaker and film promoter * Michael Dennis (artist) (born 1944), Canadian-American artist * Michael Dennis (skier) (born 1944), New Zealand Olympic skier * Mike Dennis (running back) (born 1944), American football player * Mike Dennis (defensive back) (born 1958), American football player * Mick Dennis (born 1952), sportswriter Provided by Wikipedia
Showing 1 - 13 results of 13 for search 'Mike Dennis', query time: 0.04s Refine Results
  1. 1
    Ultra‐Low Grammage Nanocellulose‐Coated Woven Fabric with Improved Aerosol Particulate Filtration Performance

    Ultra‐Low Grammage Nanocellulose‐Coated Woven Fabric with Improved Aerosol Particulate Filtration Performance by Joanne Li, Tekla Tammelin, Corinne Stone, Mike Dennis, Koon‐Yang Lee

    Published 2024-11-01
    Get full text
    Article
  2. 2
    TB and SIV Coinfection; a Model for Evaluating Vaccine Strategies against TB Reactivation in Asian Origin Cynomolgus Macaques: A Pilot Study Using BCG Vaccination

    TB and SIV Coinfection; a Model for Evaluating Vaccine Strategies against TB Reactivation in Asian Origin Cynomolgus Macaques: A Pilot Study Using BCG Vaccination by Andrew D. White, Laura Sibley, Jennie Gullick, Charlotte Sarfas, Simon Clark, Zahra Fagrouch, Ernst Verschoor, Francisco J. Salguero, Mike Dennis, Sally Sharpe

    Published 2021-08-01
    Get full text
    Article
  3. 3
    Immune cell population dynamics following neonatal BCG vaccination and aerosol BCG revaccination in rhesus macaques

    Immune cell population dynamics following neonatal BCG vaccination and aerosol BCG revaccination in rhesus macaques by Laura Sibley, Charlotte Sarfas, Alexandra L. Morrison, Jessica Williams, Konstantinos Gkolfinos, Adam Mabbutt, William Eckworth, Steve Lawrence, Mike Dennis, Andrew White, Sally Sharpe

    Published 2024-07-01
    Get full text
    Article
  4. 4
    P1677: DEFINING KEY QUALITY OF LIFE METRICS IN ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS ENROLLED IN LARGE-SCALE UK NCRI AML TRIALS

    P1677: DEFINING KEY QUALITY OF LIFE METRICS IN ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS ENROLLED IN LARGE-SCALE UK NCRI AML TRIALS by Pramila Krishnamurthy, Myrsini Gianatsi, Sophie Wintrich, Abin Thomas, Lynn Quek, Austin Kulasekararaj, Priyanka Mehta, Sreetharan Munisamy, Nigel Russell, Mike Dennis, Elspeth Payne, Ian Thomas

    Published 2023-08-01
    Get full text
    Article
  5. 5
    Outcomes of older patients aged 60 to 70 years undergoing reduced intensity transplant for acute myeloblastic leukemia: results of the NCRI acute myeloid leukemia 16 trial

    Outcomes of older patients aged 60 to 70 years undergoing reduced intensity transplant for acute myeloblastic leukemia: results of the NCRI acute myeloid leukemia 16 trial by Nigel H. Russell, Robert K. Hills, Abin Thomas, Ian Thomas, Lars Kjeldsen, Mike Dennis, Charles Craddock, Sylvie Freeman, Richard E. Clark, Alan K. Burnett

    Published 2021-10-01
    Get full text
    Article
  6. 6
    S131: A RANDOMISED ASSESSMENT OF THE SEQUENTIAL ADDITION OF THE KINASE INHIBITOR QUIZARTINIB TO INTENSIVE CHEMOTHERAPY IN OLDER ACUTE MYELOID LEUKAEMIA (AML) PATIENTS: RESULTS FROM THE NCRI AML18 TRIAL

    S131: A RANDOMISED ASSESSMENT OF THE SEQUENTIAL ADDITION OF THE KINASE INHIBITOR QUIZARTINIB TO INTENSIVE CHEMOTHERAPY IN OLDER ACUTE MYELOID LEUKAEMIA (AML) PATIENTS: RESULTS FROM... by Steven Knapper, Abin Thomas, Sophie King, Ian Thomas, Amanda Gilkes, Sarah Irwin, Robert Sellar, Simone Green, Ulrik Malthe Overgaard, Priyanka Mehta, Mike Dennis, Sylvie Freeman, Nigel Russell

    Published 2023-08-01
    Get full text
    Article
  7. 7
    P484: GEMTUZUMAB-BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. UPDATED TOXICITY AND INTERIM SURVIVAL ANALYSIS FROM THE NCRI AML19V2 “MIDOTARG” PILOT TRIAL

    P484: GEMTUZUMAB-BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. UPDATED TOXICITY AND INTERIM SURVIVAL ANALYSIS FROM THE NCRI AML19V2 “MIDOTARG” PILOT... by Nigel Russell, Oliver Cumming, Jad Othman, Richard Dillon, Nicola Potter, Charlotte Wilhelm-Benartzi, Jelena Jovanovic, Amanda Gilkes, Leona Batten, Joanna Canham, Emily Laura Hinson, Panagiotis Kottaridis, Jamie Cavenagh, Claire Arnold, Mike Dennis, Steven Knapper

    Published 2023-08-01
    Get full text
    Article
  8. 8
    S134: FLAG-IDA COMBINED WITH GEMTUZUMAB OZOGAMICIN (GO) REDUCED MRD LEVELS AND IMPROVED OVERALL SURVIVAL IN NPM1MUT AML INDEPENDENT OF FLT3 AND MRD STATUS, RESULTS FROM THE AML19 TRIAL

    S134: FLAG-IDA COMBINED WITH GEMTUZUMAB OZOGAMICIN (GO) REDUCED MRD LEVELS AND IMPROVED OVERALL SURVIVAL IN NPM1MUT AML INDEPENDENT OF FLT3 AND MRD STATUS, RESULTS FROM THE AML19 T... by Nigel Russell, Jad Othman, Richard Dillon, Nicola Potter, Charlotte Wilhelm-Benartzi, Steven Knapper, Leona Batten, Joanna Canham, Emily Laura Hinson, Ulrik Malthe Overgaard, Amanda Gilkes, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie Freeman, Mike Dennis

    Published 2023-08-01
    Get full text
    Article
  9. 9
    MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates

    MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates by Marco Polo Peralta-Álvarez, Keya Downward, Andrew White, Hugo Redondo Azema, Laura Sibley, Charlotte Sarfas, Alexandra Morrison, Mike Dennis, Delia Diaz-Santana, Stephanie A. Harris, Shuailin Li, Eugenia Puentes, Nacho Aguilo, Carlos Martin, Sally Sharpe, Helen McShane, Rachel Tanner

    Published 2024-11-01
    Get full text
    Article
  10. 10
    Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates

    Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates by Marco Polo Peralta Alvarez, Holly Jones, Hugo Redondo Azema, Chloe Davis, Andrew D. White, Charlotte Sarfas, Mike Dennis, Shuailin Li, Daniel Wright, Eugenia Puentes, Simon Kimuda, Sandra Belij-Rammerstorfer, Nacho Aguilo, Carlos Martin, Sally Sharpe, Helen McShane, Rachel Tanner

    Published 2024-05-01
    Get full text
    Article
  11. 11
    MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies

    MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies by Andrew D. White, Laura Sibley, Charlotte Sarfas, Alexandra Morrison, Jennie Gullick, Simon Clark, Fergus Gleeson, Anthony McIntyre, Cecilia Lindestam Arlehamn, Alessandro Sette, Francisco J. Salguero, Emma Rayner, Esteban Rodriguez, Eugenia Puentes, Dominick Laddy, Ann Williams, Mike Dennis, Carlos Martin, Sally Sharpe

    Published 2021-01-01
    Get full text
    Article
  12. 12
    Determination of the Pharmacokinetics and Pharmacodynamics of Isoniazid, Rifampicin, Pyrazinamide and Ethambutol in a Cross-Over Cynomolgus Macaque Model of <i>Mycobacterium tuberculosis</i> Infection

    Determination of the Pharmacokinetics and Pharmacodynamics of Isoniazid, Rifampicin, Pyrazinamide and Ethambutol in a Cross-Over Cynomolgus Macaque Model of <i>Mycobacterium tuberc... by Laura Sibley, Andrew D. White, Charlotte Sarfas, Jennie Gullick, Fergus Gleeson, Faye Lanni, Simon Clark, Emma Rayner, Santiago Ferrer-Bazaga, Fatima Ortega-Muro, Laura Alameda, Joaquin Rullas, Veronica Sousa, Marisa Martinez, Inigo Angulo-Barturen, Adolfo Garcia, Juan José Vaquero, Henry E. Pertinez, Geraint Davies, Mike Dennis, Ann Williams, Sally Sharpe

    Published 2022-11-01
    Get full text
    Article
  13. 13
    Spore-FP1 tuberculosis mucosal vaccine candidate is highly protective in guinea pigs but fails to improve on BCG-conferred protection in non-human primates

    Spore-FP1 tuberculosis mucosal vaccine candidate is highly protective in guinea pigs but fails to improve on BCG-conferred protection in non-human primates by Andrew D. White, Andy C. Tran, Laura Sibley, Charlotte Sarfas, Alexandra L. Morrison, Steve Lawrence, Mike Dennis, Simon Clark, Sirine Zadi, Faye Lanni, Emma Rayner, Alastair Copland, Peter Hart, Gil Reynolds Diogo, Matthew J. Paul, Miyoung Kim, Fergus Gleeson, Francisco J. Salguero, Mahavir Singh, Matthias Stehr, Simon M. Cutting, Simon M. Cutting, Juan I. Basile, Martin E. Rottenberg, Ann Williams, Sally A. Sharpe, Rajko Reljic

    Published 2023-10-01
    Get full text
    Article

Search Tools: